SMARCA2 and non-small cell lung carcinoma: In the study by Herpel et al. [10] involving 316 specimens of NSCLC, loss of SMARCA4 was shown in 5.1% of cases, loss of SMARCA2 in 4.8%, and concurrent loss of both markers in only four cases.